Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Preferred Shares Issued (2020 - 2021)

Design Therapeutics' Preferred Shares Issued history spans 2 years, with the latest figure at $124.7 million for Q1 2021.

  • For Q1 2021, Preferred Shares Issued rose 179.0% year-over-year to $124.7 million; the TTM value through Dec 2021 reached $124.7 million, up 178.8%, while the annual FY2021 figure was $124.7 million, 178.8% up from the prior year.
  • Preferred Shares Issued for Q1 2021 was $124.7 million at Design Therapeutics, up from $31000.0 in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $124.7 million in Q1 2021 and bottomed at $31000.0 in Q2 2020.